Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study.

MLA

Del Paggio, Joseph C., et al. “Cost and Value of Cancer Medicines in a Single-Payer Public Health System in Ontario, Canada: A Cross-Sectional Study.” Lancet Oncology, vol. 25, no. 4, Apr. 2024, pp. 431–38. EBSCOhost, https://doi.org/10.1016/S1470-2045(24)00072-X.

APA

Del Paggio, J. C., Naipaul, R., Gavura, S., Mercer, R. E., Koven, R., Gyawali, B., Wilson, B. E., & Booth, C. M. (2024). Cost and value of cancer medicines in a single-payer public health system in Ontario, Canada: a cross-sectional study. Lancet Oncology, 25(4), 431–438. https://doi.org/10.1016/S1470-2045(24)00072-X

Chicago

Del Paggio, Joseph C, Rohini Naipaul, Scott Gavura, Rebecca E Mercer, Rachel Koven, Bishal Gyawali, Brooke E Wilson, and Christopher M Booth. 2024. “Cost and Value of Cancer Medicines in a Single-Payer Public Health System in Ontario, Canada: A Cross-Sectional Study.” Lancet Oncology 25 (4): 431–38. doi:10.1016/S1470-2045(24)00072-X.